Inland Peptides

Peptide News

News

FDA Requires GLP-1 Drug Labels to Warn of a Possible Rare Vision-Loss Risk

November 9, 2026

The FDA now requires every GLP-1 drug label, including Ozempic, Wegovy, Mounjaro and Zepbound, to warn of NAION, a rare eye condition that can…

Read more →
News

French Study Finds No Clear Overall Rise in Major Birth Defects With Early GLP-1 Exposure

November 8, 2026

Researchers compared early GLP-1 prescriptions with insulin alone in women with type 2 diabetes. One analysis raised a question about heart defects.

Read more →
News

The Peptide Boom: What Surveys Reveal About Use and the Gray Market

November 2, 2026

Surveys report peptide buying from research websites and social media, interest in prescriptions, and growing payments to gray-market sellers.

Read more →
News

Peptide Cancer Vaccine Shows Strong Immune Response but Misses Main Trial Goal

October 28, 2026

A peptide vaccine for pancreatic cancer produced a strong T-cell response in a Phase 2 trial but missed its primary endpoint for recurrence-free survival.

Read more →
News

Can Peptides Send You to the Hospital? What Regulators and Lab Tests Have Documented

October 25, 2026

NSW recorded 1,180 emergency visits mentioning peptide use. What hospital cases, FDA reports and independent lab testing of gray-market peptides actually establish, and what…

Read more →
News

CagriSema Shows 25% Average Weight Loss in Women, New Trial Analysis Finds

October 22, 2026

A new REDEFINE 1 analysis reports an estimated 25% average weight loss among women on CagriSema, with results across menopause stages. The drug remains…

Read more →
News

FDA peptide compounding proposal reaches the White House

October 15, 2026

The FDA is weighing temporary enforcement discretion that could let pharmacies compound certain peptides, including BPC-157. The proposal reached the White House on Oct.…

Read more →
News

Retatrutide’s One-Amino-Acid Dispute: Why Lilly Is Challenging the FDA

October 10, 2026

Why are Lilly and the FDA disputing retatrutide’s amino-acid count? Learn how its classification could affect approval pathways and future competition.

Read more →
News

Peptide Use Is on the Rise as Americans Turn to Experimental Wellness Treatments

October 2, 2026

Nearly half of surveyed U.S. physicians say patients have reported using non-FDA-approved peptides. What is driving the trend, what the evidence shows, and how…

Read more →
News

Peptide Scams: How Dishonest Sellers Are Undermining Trust in the Peptide Market

September 13, 2026

An investigation into disguised Facebook listings, repeated ads under different names, questionable business identities and research-only marketing, with the red flags buyers can check.

Read more →